MindMaze
The deal comes less than a month after the company's plan to combine with digital neurotherapy company MindMaze fell through.
The company also seeks to sell its U.K. business to third parties, exit the U.S. market and continue trying to sell Meritage Medical Network.
The digital health company has accepted a take-private proposal from AlbaCore Capital.
Tasso received a CE Mark for its blood collection device, and MindMaze launched Izar, a smart peripheral to help improve a user's hand motor function.
New York-based Mount Sinai Health System will deploy home-based care and an outpatient rehab program using MindMaze's tools.
Also: Mental health chatbot Woebot Health brings on Moses Ike as the company's first chief financial officer, and digital neurotherapeutic maker MindMaze announces a slew of new leadership hires.
The financing comes on the heels of a $125 million raise from October.
MindMaze said the funds will allow it to accelerate the commercialization of its rehab tools and expand its brain-repair products.
MindMaze creates gamified digital neurotherapeutics for patients with neurological injuries and conditions such as stroke, traumatic brain injury, multiple sclerosis or Parkinson’s disease.
MindMaze said that it plans to continue development of NMI's gamified therapy for cognitive and motor capability impairment.